🏢 The 154,000-sq-ft space aims to support the growing biopharma industry in Greater Boston.
⚙️ It features advanced design elements, reducing costs and build time for tenants.
⌛ Tenant fit-out is expected to begin in Q2 2026, with completion projected for Q3 2026.
Introduction:
GenesisM, a collaboration between Bain Capital Real Estate and Botanic Properties, has initiated construction on a new 154,000-square-foot biomanufacturing facility in Bedford, Massachusetts, contributing to the Greater Boston area’s status as a leading biopharma cluster. This facility aims to address the urgent demand for specialized life sciences manufacturing infrastructure in the region.
- The new facility will feature advanced design elements intended to facilitate quick operations, including an enhanced core layout that minimizes tenant fit-out time and capital costs.
- Designed to accommodate multiple independent tenants, the facility will include regulated manufacturing suites with significant operational features such as 27-foot ceiling heights and 12,000 amps of power.
- GenesisM’s design emphasizes long-term operational flexibility, significantly accelerating buildout timelines while reducing upfront costs for tenants.
- Construction is currently ongoing, with tenant fit-out expected to commence in the second quarter of 2026, while core and shell delivery is anticipated in the third quarter of the same year.
- This development is poised to play a crucial role in meeting the growing needs of life sciences companies in the Greater Boston area, fostering an environment conducive to further innovations in biomanufacturing.
Conclusion:
The establishment of GenesisM’s biomanufacturing facility marks a significant advancement in the Greater Boston area’s life sciences landscape. With its strategic design and construction timeline, the facility is expected to provide essential resources and flexibility for tenants, ultimately supporting the continuous growth and innovation in the region’s biopharma sector.
